Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-03 6:56 pm Purchase | 2023-12-31 | 13G | TRANSGLOBE ENERGY CORP TGA | SABBY MANAGEMENT LLC | 5,338,587 11.000% | 5,338,587 (New Position) | Filing History |
| 2024-01-03 5:43 pm Purchase | 2023-12-31 | 13G | InMed Pharmaceuticals Inc. INM | SABBY MANAGEMENT LLC | 26,249 11.000% | 26,249 (New Position) | Filing History |
| 2024-01-03 4:59 pm Purchase | 2023-12-31 | 13G | Lipella Pharmaceuticals Inc. LIPO | SABBY MANAGEMENT LLC | 72,477 11.000% | 72,477 (New Position) | Filing History |
| 2024-01-03 4:44 pm Purchase | 2023-12-31 | 13G | Bluejay Diagnostics, Inc. BJDX | SABBY MANAGEMENT LLC | 111 11.000% | 81 (+264.83%) | Filing History |
| 2024-01-03 4:23 pm Purchase | 2023-12-31 | 13G | Tonix Pharmaceuticals Holding Corp. TNXP | SABBY MANAGEMENT LLC | 1,627 11.000% | 1,627 (New Position) | Filing History |
| 2024-01-03 3:59 pm Purchase | 2023-12-31 | 13G | Fangdd Network Group Ltd. DUO | SABBY MANAGEMENT LLC | 37,527 11.000% | 37,527 (New Position) | Filing History |
| 2024-01-03 1:54 pm Purchase | 2023-12-31 | 13G | GlucoTrack, Inc. GCTK | SABBY MANAGEMENT LLC | 6,957 11.000% | 6,957 (New Position) | Filing History |
| 2024-01-03 1:30 pm Purchase | 2023-12-31 | 13G | Recon Technology, Ltd. RCON | SABBY MANAGEMENT LLC | 191,797 11.000% | 109,460 (+132.94%) | Filing History |
| 2024-01-03 12:26 pm Purchase | 2023-12-31 | 13G | Arcadia Biosciences, Inc. RKDA | SABBY MANAGEMENT LLC | 97,305 11.000% | 91,348 (+1533.54%) | Filing History |
| 2024-01-03 09:26 am Purchase | 2023-12-31 | 13G | Mobiquity Technologies, Inc. MOBQ | SABBY MANAGEMENT LLC | 144,867 11.000% | 144,867 (New Position) | Filing History |
| 2024-01-03 08:36 am Purchase | 2023-12-31 | 13G | Revelation Biosciences, Inc. REVB | SABBY MANAGEMENT LLC | 70 11.000% | 70 (New Position) | Filing History |
| 2024-01-03 08:18 am Sale | 2023-12-31 | 13G | MMEX Resources Corporation MMEX | SABBY MANAGEMENT LLC | 844,654,010 11.000% | -7,610,341,086 (-90.01%) | Filing History |
| 2024-01-03 08:14 am Purchase | 2023-12-31 | 13G | MMEX Resources Corporation MMEX | SABBY MANAGEMENT LLC | 8,454,995,096 11.000% | 8,454,995,096 (New Position) | Filing History |
| 2024-01-02 4:54 pm Sale | 2023-12-31 | 13G | BiondVax Pharmaceuticals Ltd. BVXV | SABBY MANAGEMENT LLC | 220,663 11.000% | -7,666 (-3.36%) | Filing History |
| 2024-01-02 4:26 pm Sale | 2023-12-31 | 13G | RedHill Biopharma Ltd. RDHL | SABBY MANAGEMENT LLC | 0 0.000% | -301,616 (Position Closed) | Filing History |
| 2024-01-02 4:13 pm Sale | 2023-12-31 | 13G | Huadi International Group Co., Ltd. HUDI | SABBY MANAGEMENT LLC | 0 0.000% | -1,422,494 (Position Closed) | Filing History |
| 2024-01-02 4:05 pm Sale | 2023-12-31 | 13G | Kiromic BioPharma, Inc. KRBP | SABBY MANAGEMENT LLC | 0 0.000% | -60,762 (Position Closed) | Filing History |
| 2024-01-02 3:45 pm Purchase | 2023-12-31 | 13G | Avenue Therapeutics, Inc. ATXI | SABBY MANAGEMENT LLC | 8,814 11.000% | 5,294 (+150.40%) | Filing History |
| 2024-01-02 3:34 pm Purchase | 2023-12-31 | 13G | Bone Biologics Corporation BBLG | SABBY MANAGEMENT LLC | 1,646 11.000% | 787 (+91.60%) | Filing History |
| 2024-01-02 3:10 pm Purchase | 2023-12-31 | 13G | Aditxt, Inc. ADTX | SABBY MANAGEMENT LLC | 0 11.000% | 0 (+112.15%) | Filing History |